Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Aphton seeks E.U. clearance for G17DT trial in GERD

Aug. 26, 2002

FDA issues non approval letter for Helicide

Aug. 23, 2002

Thalidomide reported to be effective in the short-term treatment of symptomatic IBD

Aug. 23, 2002

Successful treatment of severe alcoholic hepatitis with urinastarine

Aug. 22, 2002

Adolor enters opioid antagonist license agreement with Lilly

Aug. 20, 2002

FDA approves pediatric labeling of Prevacid

Aug. 9, 2002

HCV NS3 protease inhibitors prepared and tested at Schering-Plough

Aug. 8, 2002

FDA advisory committee recommends approval of adefovir dipivoxil for chronic hepatitis B

Aug. 8, 2002

aaiPharma and Tanabe Seiyaku form joint venture

Aug. 2, 2002

Phase III results of CDP-571 in Crohn's disease

Aug. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...